Previous close | 278.50 |
Open | 278.50 |
Bid | 278.80 x 0 |
Ask | 278.90 x 0 |
Day's range | 277.90 - 278.50 |
52-week range | 199.70 - 299.40 |
Volume | |
Avg. volume | 17 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The latest trading day saw Amgen (AMGN) settling at $298.50, representing a -0.86% change from its previous close.
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
Viridian (VRDN) intends to initiate two late-stage studies on its experimental thyroid eye disease drug this August. Top-line data from both studies are expected in first-half 2026